Twist Bioscience (TWST) Cash from Operations (2017 - 2026)

Twist Bioscience has disclosed Cash from Operations across 10 years of filings, most recently posting 17559000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 35.21% year-over-year to 17559000.0; the TTM figure through Mar 2026 stood at 55587000.0 (up 0.94% YoY), while the FY2025 annual figure was 47628000.0, up 25.69% from the prior year.
• Cash from Operations climbed to 17559000.0 in Q1 2026, from 24814000.0 in the prior quarter.
• Over the last five years, Cash from Operations for TWST reached as high as 1267000.0 in Q3 2022 and fell as low as 54070000.0 in Q4 2022.
• The 5-year median for Cash from Operations is 20704000.0 (2023), against an average of 22017705.88.
• Annual changes were most pronounced in 2022 — Cash from Operations jumped 96.36% — and 2023, when it tumbled 1534.1%.
• A 5-year view of Cash from Operations shows it stood at 54070000.0 in 2022, then surged by 57.51% to 22973000.0 in 2023, then climbed by 6.73% to 21428000.0 in 2024, then declined by 15.8% to 24814000.0 in 2025, then rose by 29.24% to 17559000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 17559000.0, 24814000.0, and 11814000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.